Hachem, Yasmina
Abdallah, Sara J.
Rueda, Sergio
Wiese, Jessica L.
Mehra, Kamna
Rup, Jennifer
Cowan, Juthaporn
Vigano, Antonio
Costiniuk, Cecilia T.
Article History
Received: 9 June 2022
Accepted: 2 September 2022
First Online: 8 September 2022
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained by all participants. Ethics approval was obtained from the MUHC REB (2021–7584).
: Not applicable.
: CTC receives study drug from Tilray Inc. for use in conducting a clinical trial but otherwise has no COIs to declare related to cannabis or cannabinoid-based medicines. AV was a former advisory board member of Spectrum Therapeutics/Canopy Health, Tilray, Tetrabiopharma, Syqe. He was the former Research Director of Santé Cannabis in Montreal, Canada. He otherwise has no COIs to declare. SJA, SR, JLW, JC, KM, JR, and YH have no potential COIs to declare.